Astellas Pharma Inc. (ALPMY) News
Track canonical SquawkNews coverage tagged to ALPMY, Astellas Pharma Inc.. This hub brings together deduplicated headlines about otc markets otcpk, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Pfizer, Astellas announces FDA approval of PADCEV plus Keytruda in MIBC
Pfizer (PFE) and Astellas Pharma (ALPMY) announced that the U.S. Food and Drug Administration has approved PADCEV, a Nectin-4 directed antibody-drug conjugate, plus the PD-1 inhibitor, Keytruda or Keytruda QLEX as neoadj
COMMODITIES | Jul 10, 2026, 03:26 PM UTC
H
SGMO Files Chapter 11
Sangamo Therapeutics files for Chapter 11 bankruptcy protection and agrees to sell assets to Eli Lilly and Astellas Pharma
EQUITY | Jun 23, 2026, 05:48 PM UTC